KIDRON NADAV

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
KIDRON NADAV's trades of Oramed Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
139.49
Quantity 14,801 -49.4%
Value US$4,829,504
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-16 2023-03-16
B Purchase
61,357 +45.4%
69.17
US$2,847,208 		61,357 +45.4% 69.17 US$2,847,208
2023-03-15 2023-03-14
B Purchase
14,801 -49.4%
139.49
US$4,829,504 		14,801 -49.4% 139.49 US$4,829,504
2021-08-11 2021-08-09
PlS Planned sale
83,811 -47.0%
135.20
US$4,747,193 		83,811 -47.0% 135.20 US$4,747,193